Objective. The objective of this study is to describe the presentation and management of sudden sensorineural hearing loss for patients seen in academic and community-based practices within the context of the American Academy of Otolaryngology-Head and Neck Surgery Foundation's ''Clinical Practice Guideline: Sudden Hearing Loss.'' The intention is to use these findings to guide implementation strategies and quality improvement initiatives and as pilot data for the development of clinical research initiatives.
S udden hearing loss (SHL) is rapid onset of subjective hearing loss .3 days. Sudden sensorineural hearing loss (SSNHL) is a subset of SHL where the hearing loss is sensorineural in nature. If there is no identifiable underlying cause after appropriate evaluation, the term idiopathic SSNHL (ISSNHL) is often applied. Although SSNHL is primarily a disease of middle age, with a median age of 48 years, cases have been reported in people of nearly all ages. 1 Not all patients with SSNHL present to an otolaryngologist's office for timely evaluation and definitive diagnosis. The true incidence of the disease is difficult to assess, but most current estimates are between 2 and 20 individuals per 100,000. 2, 3 No convincing epidemiologic risk factors for unilateral SSNHL have been distinctly identified to date. [4] [5] [6] Different investigators have implicated viruses, ischemic phenomena, and autoimmune processes, but no definitive evidence exists identifying a causative agent. [7] [8] [9] [10] Patients with SSNHL typically present with sudden loss of hearing or a loss of hearing upon awakening, which is usually unilateral. 11 There is often associated tinnitus and sensation of ear pressure. Ear examination of a patient with SSNHL reveals no anatomic abnormalities, while the audiogram confirms elevated hearing thresholds in the affected ear.
The 2012 American Academy of Otolaryngology-Head and Neck Surgery Foundation's (AAO-HNSF's) clinical practice guideline (CPG) on the management of SHL provides recommendations to facilitate the timely and appropriate evaluation and management of patients presenting with SHL and specifically SSNHL. 3 This guideline was derived from a multidisciplinary panel that carefully examined the available literature to arrive at evidence-based recommendations in the form of key action statements (KASs; see appendix). The implementation and knowledge distribution strategy for the guideline includes publication in the specialty's journal, presentation of findings at the annual meeting of the AAO-HNSF, development of corresponding educational materials geared toward multiple audiencesconsumer and provider alike-and provision of the guideline through the Internet publicly and free of charge.
The goal of our study was to describe the alignment between the guideline and the management experience of patients with SHL. Specifically, we wanted to describe triage of the SHL patient population and quantify compliance with selected guideline KASs.
We hypothesized that while overall adherence to the guideline by otolaryngologists would be high, there would remain opportunity for improved alignment between practice and evidence, including improved resource utilization.
Methods
This cross-sectional study utilized the Creating Healthcare Excellence through Education and Research (CHEER) network for recruitment. 12 Patients were recruited in 16 participating CHEER sites between July 11, 2013, and January 17, 2015. Eight participating sites were academic, and 8 were community based. This study was approved by the Duke University School of Medicine's Institutional Review Board (IRB). Community-based sites without their own IRBs were covered under Duke University's IRB approval. Other sites received approval from their own IRBs.
To be eligible, patients were required to meet the following 3 criteria: symmetrical hearing prior to the incident of hearing loss (subjective with no requirement for a prior hearing test); new-onset hearing loss in only 1 ear; and a nonaffected ear, which could be used as baseline comparator. Patients were excluded if they presented with bilateral SHL, a history of recurrent episodes of SHL, or if there were focal neurologic findings. These criteria encompass the definition set forth in the AAO-HNSF's CPG on SHL. 4 The case report form was a questionnaire that was developed with input and review from otology-neurotology experts from within the CHEER network leadership and reviewed by the AAO-HNSF's CPG panel leadership for SHL. The case report form included relevant information from both the patient and the provider and was collected on paper and recorded via REDCap, a secure and appropriate online platform for clinical research. 2 The main purpose of this study was to describe the patient population in terms of provider compliance with the CPG KASs. We also sought to describe the patient's care pathway to the otolaryngologist. A substudy regarding use of steroids will be described in a subsequent article. Recruitment goals were based on power analysis scenarios generated for the substudy. Data were analyzed in Microsoft Excel and SAS 9.3 1 (SAS Institute Inc, Cary, North Carolina) and included descriptive analyses and correlation statistics between key variables.
Results

Patient Characteristics
The data set included 175 patients. The audiometric data of 2 patients indicated that their hearing loss was conductive, and they were excluded. Of the 173 evaluable patients, 31 had 1 conditions that have been implicated as possible causes of sensorineural hearing loss and may have associated treatment needs that would affect the care path. A total of 142 patients (82.1%) had ISSNHL with 30 dB of hearing loss at 3 consecutive frequencies. Upon enrollment in the study, 68% (n = 117) of the patients were new to the otolaryngologist. The remaining 32% (n = 56) were follow-up patients. The median patient age was 60 years, and the median number of days between SHL onset and presentation to the otolaryngologist for initial visits was 15. There was no significant association between days from onset of hearing loss and median pure tone audiometry. The majority of patients (98.8%, n = 171) indicated that this was their first occurrence of SHL. Tables 1 and 2 present the patient demographic and presenting characteristics.
Most patients (73.4%, n = 127) self-reported that they had experienced tinnitus; 65.9% (n = 114) experienced fullness; and 31.8% (n = 55) experienced dizziness in the prior 10 days before the visit to the otolaryngologist. Additionally, in this time frame, 8.1% (n = 14) of patients had experienced noise exposure (including barotrauma), and 1.2% (n = 2) had experienced trauma to the ear. For testing performed at the enrollment visit, 99.4% (n = 172) had pure tone threshold testing; 97.1% (n = 168) had speech testing; and 86.7% (n = 15) had tympanometry.
Audiometric and Examination Findings Profile
A summary of the examination findings from the enrollment visit is summarized in Tables 3 and 4 for the overall population and relevant subpopulations: those who indicated that they had received prior treatment of oral or intratympanic steroids and those with no identified potentially causative condition.
Care Pathway to the Otolaryngologist
Data were collected on the referral pathway to the otolaryngologist by provider type. Less than half of the patients (43.9%, n = 76) indicated that the first presenting visit was to either an otolaryngologist or both an otolaryngologist and an audiologist (1.2%, n = 2) on the same day. A small proportion (5.8% n = 10) indicated that they went to a primary care clinic or an emergency/urgent care facility before going to the otolaryngologist on the same day. Patients who did not see an otolaryngologist first went to primary care (28.3%, n = 49) or emergency/urgent care (20.8%, n = 36) as the first stop for treatment. Patients who went first to primary care saw the otolaryngologist, on average, 9.1 days (SD = 7.8 days) after the primary care visit. Patients who went first to emergency/urgent care saw the otolaryngologist, on average, 5.5 days (SD = 4.5 days) after the emergency/urgent care visit. There were no statistically 
Values in n (%) unless noted otherwise. 
CPG Compliance
Of the 13 guideline statements in the AAO-HNSF's CPG on SHL, 11 were assessed and/or evaluable through this study. 4 Compliance for otolaryngologists was high (.95%) for KASs 1, 3, and 6; moderate (90%-95%) for KASs 5 and 10; and low (\90%) for KASs 7 and 13. Regarding KASs 8 and 11, otolaryngologists are using the option of oral steroid therapy as initial treatment and do offer intratympanic steroid therapy for salvage. Statements 2, 4, 9, 11 , and 12 could not be fully addressed by our study design, although 9, 11, and 12 are further addressed in the substudy. According to this study, there is opportunity for nonotolaryngologists to improve for statements 3 and 5-7. Table S1 (see www.otojournal.org/supplemental) provides a summary of the assessment.
Discussion
The purpose of this study was to describe the management pattern for providers who evaluated and treated patients presenting with SSNHL. We then translated these reported patterns into compliance rates for the applicable KASs of the SSNHL CPG published in 2012. The study was conducted in the CHEER practice-based research network as an observational study of current practice. This was the AAO-HNF's first study to evaluate guideline compliance either within or outside our specialty. Evidence-based CPGs are developed by reviewing important published information to enhance consistency of care, identify needed quality improvement activities, and support coverage and reimbursement for appropriate care. The development of guidelines by the AAO-HNSF is structured in a multidisciplinary manner to ensure that the guidelines have relevance for nonotolaryngologists, who often are the entry point for patients presenting with a new ear, nose, or throat complaint.
The SHL guideline is structured and written to facilitate implementation in practice. This includes checklists for diagnoses, summary statements, and a categorization of the strength of evidence and management for each statement. This study begins to assess which KASs otolaryngologists and other providers are complying with and which statements are proving more difficult to implement; this ideally will guide future quality improvement activities.
Our results show that otolaryngologists had high compliance in KASs that were actionable within an evaluation and treatment algorithm. This is consistent with our surveybased assessment of the KASs, completed at the 2012 annual meeting mini-seminar, which showed compliance of 95% among attendees. The low-compliance KASs were those that centered on counseling and education (Table S1 ). These activities can be very time-consuming when compared with interpreting an audiogram or ordering magnetic resonance imaging. As health care moves closer to measuring patient perceptions for reimbursement, effective educational strategies must be developed to meet these metrics while efficiently using the time of the physicians and patients. Continuous quality improvement initiatives will potentially help address this deficiency through development of actionable educational strategies for both provider and patient.
Education and shared decision making are important components for appropriate management of patients with SSNHL. Therefore, conversations with effective exchange of information regarding possible etiologies of the hearing loss, available treatments with associated benefits and risks, and rehabilitation services need both documentation and intentional incorporation into the patients' episodes of care. Readily available strategies to address many of the lowcompliance KASs include patient education through a leaflet/brochure or as part of the printed after-visit summary, for those with an electronic health record. Additionally, the AAO-HNSF offers a webpage for frequently asked questions, podcasts, and plain-language summaries to supplement patient education for selected SHL KASs. Improved awareness and distribution of these materials and strategies would likely improve perceived and actual compliance as well as overall patient satisfaction and care.
Limitations
All but 1 participating site (Central Oregon ENT) have neurotologists in the practices, but provider per patient was not captured in the study. Statement 4 directs the clinician's diagnosis. Our enrollment criteria were in concordance with statement 4, but we did not ask providers for information on their overall diagnostic patterns, which may differ.
It is possible that some patients were offered education that was not documented in the electronic medical record or a hearing aid evaluation that was declined, not scheduled, or missed and not documented to the study. There may also be established referral patterns to specialists that are influencing the data but not clearly captured in this study.
We also note that the proportion of minority patients who enrolled this study is significantly less than what would be expected from our CHEER site database (23.6% minority or ethnic). This may represent a reluctance of provider or patient to enroll in this study or other unknown reasons, rather than a race-related risk in the epidemiology of SSNHL.
Last, we did not evaluate the outcome associated with different treatments in this study, since it is focused on compliance with KASs in the SHL guideline. A second analysis is underway to describe the outcomes of patients who received oral and/or intratympanic steroid therapy.
Conclusion
Most patients with ISSNHL were new visits to the otolaryngologist. Most are middle aged (in their 60s) and are seen by the ear, nose, and throat specialist in 15 days. Patients can present with tinnitus, ear fullness, and dizziness. Less than half of the patients (43%) saw the otolaryngologist or audiologist initially. If the patient presents to the emergency room first, his or her likelihood of seeing the specialist earlier is greater, but this earlier path to treatment does not affect the resultant pure tone audiometry. Many patients are treated with steroids. Otolaryngologists are compliant with the majority of the CPGs, except for those based on education and counseling. Perhaps effective educational strategies can be developed to aid the ear, nose, and throat doctor to obtain better compliance with the KASs. There are many opportunities for the nonotolaryngologist to improve in not ordering computed tomography scans of the head and laboratory tests for patients with ISSNHL. These physicians should also order magnetic resonance imaging or auditory brainstem response to rule out retrocochlear pathology, and they should try to educate the patients about the nuances in ISSNHL. Quality is ultimately improved with a clearer knowledge of how to evaluate and treat this particular condition. 
Appendix: Key Action Statements
